Clinical Evaluation of the Cutaneous Phototoxicity of 5,10,15,20-Tetra (m-hydroxyphenyl)chlorin

Photochemistry and Photobiology

Volumn 68, Issue 3, 1998, Pages 382-387

  Wagnieres, Georges ^a   Hadjur, Christophe ^a   Grosjean, Pierre ^b   Braichotte, Daniel ^a   Savary, Jean François ^b   Monnier, Philippe ^b   Van Den Bergh, Hubert ^a  

^a EPFL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MESOPORPHYRIN; PHOTOSENSITIZING AGENT; TEMOPORFIN;

ARTICLE; DOSE RESPONSE; DRUG EFFECT; HUMAN; LIGHT; PATHOLOGY; RADIATION EXPOSURE; SKIN; TIME;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIGHT; MESOPORPHYRINS; PHOTOSENSITIZING AGENTS; SKIN; TIME FACTORS;

EID: 0032159585     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.1998.tb09696.x     Document Type: Article

References (41)

1. Kessel, D. (1990) Photodynamic Therapy of Neoplastic Disease, Vols. I and II. CRC Press, Boca Raton, FL.
2. Spinelli, P., M. Dal Fante and R. Marchesini (1992) Photodynamic Therapy and Biomedical Lasers. Excerpta Medica, Amsterdam, The Netherlands.
3. Pass, H. I. (1993) Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst. 85, 443-456.
4. Stables, G. I. and D. V. Ash (1995) Photodynamic therapy. Cancer Treatment Rev. 21, 311-323.
5. Edell, E. S. and D. A. Cortese (1995) Photodynamic therapy: its use in the management of bronchogenic carcinoma. Clin. Chest Med. 16, 455-463.
6. Schuitmaker, J. J., P. Baas, H. L. L. M. van Leengoed, F. W. van den Meulen, W. M. Star and N. Zandwijk (1996) Photodynamic therapy: a promising new modality for the treatment of cancer. J. Photochem. Photobiol. B Biol. 34, 3-12.
7. Fisher, A. M. R., A. L. Murphree and C. J. Gomer (1995) Clinical and preclinical photodynamic therapy. Lasers Surg. Med. 17, 2-31.
8. Levy, J. G. (1995) Photodynamic therapy. Trends Biotechnol. 13, 14-18.
9. Evensen, J. F. (1995) The use of porphyrins and nonionizing radiation for treatment of cancer. Acta Oncol. 34, 1103-1110.
10. Grosjean, P., J.-F. Savary, G. A. Wagnières, J. Mizeret, A. Woodtli, J.-F. Theumann, C. Fontolliet, H. E. van den Bergh and P. Monnier (1996) Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and esophageal cancers. Lasers Med. Sci. 11, 227-235.
11. Grosjean, P., J.-F. Savary, J. Mizeret, G. A. Wagnières, A. Woodtli, J.-F. Theumann, C. Fontolliet, H. E. van den Bergh and P. Monnier (1996) Photodynamic therapy for cancer of the upper aerodigestivc tract using tetra(m-hydroxyphenyl)chlorin. J. Clin. Laser Med. & Surg. 14, 281-287.
12. Grosjean, P., G. A. Wagnières, C. Fontolliet, H. E. van den Bergh and P. Monnier (1998) Clinical photodynamic therapy with Photofrin II and 514 nm light for superficial cancers in the oesophagus and the bronchi. Br. J. Cancer. 77, 1989-1995.
13. Savary, J.-F., Ph. Monnier, Ch. Fontolliet, J. Mizeret, G. A. Wagnières, D. R. Braichotte and H. E. van den Bergh (1997) Photodynamic therapy for early squamous cell carcinomas of the eosophagus, bronchi and mouth with m-tetra(hydroxyphenyl)chlorin. Arch. Otolaryngol. Head Neck Surg. 123, 162-168.
14. Savary, J.-F., P. Monnier, C. Fontolliet, G. A. Wagnières, D. R. Braichotte and H. E. van den Bergh (1998) Photodynamic therapy of early squamous cell carcinomas of the eosophagus: a review of 31 cases. Endoscopy. 30, 258-265.
15. Bays, R., G. A. Wagnières, D. Robert, D. R. Braichotte, J.-F. Savary, P. Monnier and H. E. van den Bergh (1997) Light dosimetry for photodynamic therapy in the esophagus. Lasers Surg. Med. 20, 290-303.
16. Edell, E. S. and D. A. Cortese (1992) Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 102, 1319-1322.
17. Sibille, A., R. Lambert, J.-C. Souquet, G. Sabben and F. Descos (1995) Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 108, 337-344.
18. Kato, H., T. Horai, K. Furuse, M. Fukuoka, S. Suzuki, Y. Hiki, Y. Ito, S. Mimura, Y. Tenjin, H. Hisazumi and Y. Hayata (1993) Photodynamic therapy for cancers: a clinical trial of porfimer sodium in Japan. Jpn. J. Cancer Res. 84, 1209-1214.
19. Monnier, P., M. Savary, C. Fontolliet, G. A. Wagnières, A. Châtelain, P. Cornaz, C. Depeursinge and H. E. van den Bergh (1990) Photodetection and photodynamic therapy of "early" squamous cell carcinomas of the pharynx, oesophagus and tracheo-bronchial tree. Lasers Med. Sci. 5, 149-169.
20. Monnier, P., C. Fontolliet, G. A. Wagnières, D. R. Braichotte and H. E. van den Bergh (1992) Further appraisal of PDI and PDT of early squamous cell carcinomas of the pharynx, oesophagus and bronchi. In Photodynamic Therapy and Biomedical Lasers (Edited by P. Spinelli, M. Dalfante and R. Marchesini), pp. 7-14. Elsevier Science, Amsterdam, The Netherlands.
21. Berenbaum, M. C., R. Bonnett and P. A. Scourides (1982) In vivo biological activity of the components of haematoporphyrin derivative. Br. J. Cancer 45, 571-581.
22. Wagnières, G. A. , D. R. Braichotte, S. Folli, H. E. van den Bergh and A. Châtelain (1994) Measurement of the Photofrin II absolute fluorescence quantum yield in tissue. Photochem. Photobiol. 59, 81S.
23. Dougherty, T. J., M. T. Cooper and T. S. Mang (1990) Cutaneous phototoxic occurences in patients receiving Photofrin. Lasers Surg. Med. 10, 485-488.
24. Mullooly, V. M., A. L. Abramson and M. J. Shikowitz (1990) Dihematoporphyrin ether-induced photosensitivity in laryngeal papilloma patients. Lasers Surg. Med. 10, 349-356.
25. Berenbaum, M. C., R. Bonnett, E. B. Chevretton, S. L. Akande-Adebakin and M. Ruston (1993) Selectivity of meso-tetra-(hydroxyphenyl)porphyrins and chlorins and Photofrin in causing photodamage in tumor, skin, muscle and bladder. The concept of cost-benefit in analysing the results. Lasers Med. Sci. 8, 235-243.
26. Savary, J.-F., P. Monnier, G. A. Wagnières, D. R. Braichotte, C. Fontolliet and H. E. van den Bergh (1993) Preliminary clinical studies of photodynamic therapy with meso-tetrahydroxyphenyl chlorin (m-THPC) as a photosensitizing agent for the treatment of early pharyngeal, esophageal and bronchial carcinomas. Proc. Soc. Photo-Opt. Instr. Eng. 2078, 330-340.
27. Van Geel, I. P. J., H. Oppelaar, Y. G. Oussoren, M. A. Vandervalk and F. A. Stewart (1995) Photosensitizing efficacy of mTHPC-PDT compared to Photofrin-PDT in the RIF1 mouse tumour and normal skin. Int. J. Cancer 60, 388-394.
28. Ma, L., J. Moan and K. Berg (1994) Evaluation of a new photosensitizer, meso-tetrahydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers. Int. J. Cancer 57, 883-888.
29. Dilkes, M. G., M. L. DeJode, Q. Gardiner, G. S. Kenyon and P. Mckelvie (1995) Treatment of head and neck cancer with photodynamic therapy: results after one year. J. Laryngol Otol. 109, 1072-1076.
30. Ris, H.-B., H.-J. Altermatt, B. Nachbur, C. M. Stewart, Q. Wang, C. K. Lim, R. Bonnett and U. Althaus (1996) Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg. Med. 18, 39-45.
31. Morlet, L., V. Vonarx, M.-T. Foultier, A. Gouyette, C. Stewart, P. Lenz and T. Patrice (1997) In vitro and in vivo spectrofluorometry of a water-soluble meta-(tetrahydroxyphenyl)chlorin (mTHPC) derivative. J. Photochem. Photobiol. B Biol. 39, 249-257.
32. Bays, R., G. A. Wagnières, D. Robert, D. R. Braichotte, J.-F. Savary, P. Monnier and H. E. van den Bergh (1996) Clinical determination of tissue optical properties by endoscopie spatially resolved reflectometry. App. Opt. 35, 1756-1766.
33. Braichotte, D., G. A. Wagnières, R. Bays, P. Monnier and H. E. van den Bergh (1995) Clinical pharmacokinetics studies of Photofrin by fluorescence spectroscopy in the oral cavity, the esophagus, and the bronchi. Cancer 75, 2768-2778.
34. Braichotte, D. R., J. F. Savary, P. Monnier and H. E. van den Bergh (1996) Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy. Lasers Surg. Med. 19, 340-346.
35. Van Gemert, M. and A. Welch (1989) Time constant in thermal laser medicine. Lasers Surg. Med. 9, 405-421.
36. Andrejevic Blant, S., A. Woodtli, G. A. Wagnières, C. Fontolliet. H. E. van den Bergh and P. Monnier (1996) In vivo fluence rate effects in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin. Photochem. Photobiol. 64, 963-968.
37. Forrer, M., T. Glanzmann, D. R. Braichotte, G. A. Wagnières, H. E. van den Bergh, J.-F. Savary and P. Monnier (1996) In vivo measurement of fluorescence bleaching of meso-tetrahydroxyphenylchlorin (mTHPC) in the esophagus and the oral cavity. Proc. Soc. Photo-Opt. Instr. Eng. 2627, 33-39.
38. Brown, S. B., D. I. Vernon, J. A. Holroyd, S. Marcus, R. Trust, W. Hawkins, A. Shah and A. Tonelli (1992) Pharmacokinetics of photofrin in man. In Photodynamic Therapy and Biomedical Lasers (Edited by P. Spinelli, M. Dalfante and R. Marchesini), pp. 475-479. Elsevier Science, Amsterdam, The Netherlands.
39. Pantelides, M. L., J. V. Moore, E. Forbes, T. G. Truscott and J. E. Boggan (1993) The uptake of porphyrin and zinc-metalloporphyrin by the primate prostate. Photochem. Photobiol. 57, 838-841.
40. Wang, K., K. Gutta and J. Densmore (1995) The use of laser induced fluorescence in the determination of photosensitizer concentration during photodynamic therapy of the Barrett's esophagus. Lasers Surg. Med. S7, 42.
41. Derendorf, H. and G. Hochhaus (1995) Handbook of Pharmacokinetic/Pharmacodynamic Correlation. CRC Press, Boca Raton, FL.